LogoCrystal's MCW Coder Hub

H20.00

5 min read

🧬ICD-10 CM H20.00 - Iridocyclitis, unspecified eye

Overview

ICD-10 CM H20.00 classifies Iridocyclitis, specifically when the laterality is unspecified. Iridocyclitis is a form of anterior uveitis characterized by inflammation of the iris (iritis) and the ciliary body (cyclitis). This condition can be acute or chronic and may be associated with systemic autoimmune disorders, infections, or trauma.

Accurate coding of H20.00 is essential for documenting ocular inflammation. However, coders should strive to specify laterality (Right H20.01 or Left H20.02) whenever clinical documentation supports it, as unspecified codes may impact quality metrics and risk adjustment accuracy.

Code Breakdown

The structure of H20.00 follows the ICD-10-CM taxonomy:

SegmentValueDescription
CategoryH20Iridocyclitis
SubcategoryH20.0Iridocyclitis
Extension0Unspecified eye

Laterality Specifics

  • 1: Right eye
  • 2: Left eye
  • 3: Bilateral
  • 0: Unspecified eye

Laterality Requirement

ICD-10-CM guidelines emphasize specifying laterality when known. If the medical record indicates which eye is affected, use H20.01 (Right) or H20.02 (Left). Use H20.00 only when the documentation does not specify the eye.

Coding Guidelines

Includes

  • Anterior uveitis NOS.
  • Iritis NOS.
  • Iridocyclitis NOS.
  • Primary iridocyclitis.
  • Recurrent iridocyclitis.
  • Hypopyon (if associated with iridocyclitis).

Excludes

  • Syphilitic Iridocyclitis: A52.7 (Congenital syphilis) or A52.7 (Late syphilis).
  • Tuberculous Iridocyclitis: A18.5.
  • Viral Iridocyclitis: Code first the underlying viral disease (e.g., B02.31 for Zoster iridocyclitis).
  • Fuchs Heterochromic Cyclitis: H20.2.
  • Glaucomatocyclitic Crises: H20.2.
  • Lens-Induced Iridocyclitis: H20.1.
  • Traumatic Iridocyclitis: Code first the injury with 7th character for subsequent encounter if applicable, then H20.0- if appropriate, or use specific injury code.

Use of Additional Codes

H20.00 may be coded with additional codes to fully capture the clinical picture:

  • Underlying Systemic Disease: If the iridocyclitis is associated with a systemic condition (e.g., Ankylosing Spondylitis M45.9, sarcoidosis D86.9, Rheumatoid Arthritis M06.9), code the underlying condition first or as secondary depending on the reason for encounter.
  • Visual Impairment: If the condition has resulted in vision loss, add codes from H54.-.
  • Adhesions: If there are posterior synechiae, add H21.2-.
  • Medication Use: If the patient is on long-term steroids for treatment, consider Z79.52 (Long term (current) use of steroids).

Risk Adjustment (HCC)

Hierarchical Condition Category (HCC) status determines impact on risk adjustment scores for Medicare Advantage and ACA plans.

  • HCC Status: No CMS-HCC V28
  • RAF Impact: This code does not directly contribute to the Risk Adjustment Factor (RAF) score under the current CMS-HCC V28 model.
  • Clinical Relevance: While not an HCC, chronic iridocyclitis indicates significant resource utilization (specialist visits, imaging, medications) and may trigger care management programs.

Inpatient Impact (MS-DRG)

In the inpatient setting, H20.00 influences the Medicare Severity Diagnosis Related Group (MS-DRG) assignment.

  • CC/MCC Status: Non-CC (Not a Complication/Comorbidity) CMS MS-DRG v42
  • Impact: This code generally does not shift a DRG to a higher severity tier on its own. However, it supports medical necessity for admissions related to severe complications (e.g., secondary glaucoma, hypopyon requiring intervention).
  • POA Indicator: Present on Admission (POA) reporting is required for inpatient claims.

Code Tree

Chapter 7: Diseases of the Eye and Adnexa (H00-H59)
└── Disorders of iris and ciliary body (H20-H22)
    └── Iridocyclitis (H20)
        └── Iridocyclitis (H20.0)
            └── H20.00 (Unspecified eye)
            └── H20.01 (Right eye)
            └── H20.02 (Left eye)
            └── H20.03 (Bilateral)
        └── Lens-induced iridocyclitis (H20.1)
        └── Other iridocyclitis (H20.2)
        └── Iridocyclitis, unspecified (H20.9)

Clinical Coding Examples

Example 1: Unspecified Laterality

Scenario: A patient presents with eye pain and photophobia. The provider documents “Acute Iridocyclitis” but does not specify which eye in the assessment plan, and the exam notes are ambiguous. Coding:

  • Primary: H20.00
  • Note: Query the provider to clarify laterality if possible before claim submission.

Example 2: Associated with Ankylosing Spondylitis

Scenario: Patient with known Ankylosing Spondylitis presents with flare-up of iridocyclitis in the right eye. Coding:

  • Primary: M45.9 (Ankylosing spondylitis) - If managing the systemic condition.
  • Secondary: H20.01 (Iridocyclitis, right eye) - Use specific laterality code.
  • Note: Sequence based on the reason for the encounter. If the visit is solely for the eye, H20.01 may be primary.

Example 3: Herpetic Iridocyclitis

Scenario: Patient diagnosed with Herpes Zoster Iridocyclitis in the left eye. Coding:

  • Primary: B02.31 (Zoster iridocyclitis)
  • Note: Do not use H20.00 when a specific etiology code exists that includes the eye condition.

Example 4: Chronic Condition

Scenario: Patient returns for follow-up of chronic iridocyclitis, unspecified eye. Coding:

  • Primary: H20.00
  • Secondary: Z79.52 (Long term (current) use of steroids) - If applicable.

Revenue Cycle Considerations

  • wRVU: Not Applicable. ICD-10-CM codes do not have work Relative Value Units. wRVUs are assigned to CPT/HCPCS procedure codes.
  • Assistant Payable: Not Applicable. This attribute applies to surgical CPT codes.
  • Denial Risk: Moderate. Payers may deny claims if the level of service (E/M) does not support the complexity of managing uveitis, or if laterality is unspecified when exam data exists.
  • Prior Authorization: Medications used to treat iridocyclitis (e.g., biologics, steroids) often require prior authorization supported by diagnosis codes like H20.00.
  • H20.01: Iridocyclitis, right eye
  • H20.02: Iridocyclitis, left eye
  • H20.03: Iridocyclitis, bilateral
  • H20.1: Lens-induced iridocyclitis
  • H20.2: Other iridocyclitis (e.g., Fuchs heterochromic cyclitis)
  • H20.9: Iridocyclitis, unspecified
  • H54.-: Visual impairment
  • B02.31: Zoster iridocyclitis

Clinical Management Notes

Management of H20.00 typically involves American Academy of Ophthalmology:

  • Corticosteroids: Topical, periocular, or systemic to reduce inflammation.
  • Cycloplegics: To prevent synechiae formation and reduce pain.
  • Immunosuppressive Therapy: For non-infectious uveitis refractory to steroids.
  • Monitoring: Regular intraocular pressure checks to monitor for secondary glaucoma.

Documentation should support the medical necessity of these treatments when billing associated procedure codes (e.g., 67028 for intravitreal injection).

CMS ICD-10-CM Official Guidelines for Coding and Reporting FY 2025 CMS-HCC Risk Adjustment Model V28 Summary CMS MS-DRG Definitions Manual v42 NCHS ICD-10-CM Tabular List 2025 American Academy of Ophthalmology Preferred Practice Pattern

Graph View

Recent Notes